Maryam Samir Yousif Matloub

Maryam Matloub practices at Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health.

Maryam Matloub's NPI, 1932767795, was assigned on June 5, 2019. Maryam Matloub holds Michigan license 4301508883.

Maryam Matloub's primary practice is Corewell Health William Beaumont University Hospital, at 3601 W Thirteen Mile Rd, Royal Oak, MI 48073 in Oakland County. The practice phone is (248) 898-5400.

Maryam Matloub's primary practice is Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health. The medical group on file is Beaumont Medical Group - Specialty Services. Dmand AI also links Maryam Matloub to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Maryam Matloub practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Maryam Matloub's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Maryam Matloub is licensed in Michigan.

CMS data shows 35 Medicare services from Maryam Matloub across 2 procedure codes in 2024, for 52 Medicare patients. Medicare paid $4,088 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 52 Medicare patients who saw Maryam Matloub in 2024. The largest group is 65 to 74, with 23 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 2.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Maryam Matloub's median patient age at 53, with 52% women.

In 2024, Maryam Matloub wrote 62 Medicare Part D claims for 13 patients. 89% of them were for generic drugs. CMS names the drug for 16 of them, across 1 drug with 11 or more claims each, at $700 in total drug cost. In 2022, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Maryam Matloub for performance year 2024, reported as part of a group. Maryam Matloub accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 6 general payments to Maryam Matloub from 6 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. SK Life Science, Inc. paid the most, $111.